Form 4: Guardant Health CIO Sells 5,000 Shares

Guardant Health Chief Information Officer Kumud Kalia sold 5,000 shares of common stock on June 10, 2026.

Summary

• Kumud Kalia, Chief Information Officer of Guardant Health, Inc., executed a sale of 5,000 shares of common stock.
• The transaction occurred on June 10, 2026, at an average price of $130.406 per share.
• Following this transaction, the reporting person retains beneficial ownership of 44,508 shares.
• The filing notes that the total holdings include 259 shares acquired via the Employee Stock Purchase Plan on May 14, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale of 5,000 shares is a routine transaction for an executive and does not necessarily signal a change in the company's fundamental outlook.

Positives

• The reporting person maintains a significant remaining stake of 44,508 shares in the company.

Negatives

• The transaction represents a divestment of equity by a member of the executive leadership team.

Risks

• Insider selling can sometimes be perceived by the market as a lack of confidence in near-term stock performance, though such sales are often pre-planned for liquidity or tax purposes.

Future Outlook

No forward-looking guidance or operational outlook was provided in this regulatory filing.

Industry Context

StockSavvy.ai notes that executive stock sales are common occurrences in the biotechnology and healthcare sectors, often related to personal financial planning or the exercise of equity compensation plans rather than fundamental shifts in company strategy.

Comparison to Industry Standards

• The sale of shares by an executive is a standard practice for liquidity and does not deviate from typical corporate governance patterns observed in mid-to-large cap biotech firms.
• The remaining ownership stake held by the CIO remains substantial, aligning with industry norms for executive retention.

Stakeholder Impact

• Minimal impact expected on shareholders as the transaction size is relatively small compared to the total outstanding shares.

Next Steps

• No future actions or milestones were disclosed in this filing.

Key Dates

Keywords

Guardant Health, GH, Insider Trading, Form 4, Equity Sale, Kumud Kalia